Review
Published on 12 Sep 2024
Aldehyde-induced DNA-protein crosslinks-DNA damage, repair and mutagenesis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1478373
Type at least 3 characters
2,891 articles
Articles
Original Research
Published on 11 Sep 2024
Identify BCAT1 plays an oncogenic role and promotes EMT in KIRC via single cell RNA-seq and experiment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1446324
Original Research
Accepted on 10 Sep 2024
Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1460150
Review
Published on 10 Sep 2024
Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1394292
- 188 views
Original Research
Accepted on 09 Sep 2024
Comprehensive Liquid Biopsy Analysis for Monitoring NSCLC Patients Under Second-line Osimertinib Treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435537
Original Research
Accepted on 06 Sep 2024
Extracellular vesicles from cancer cell lines of different origins drive the phenotype of normal oral fibroblasts in a CAF-like direction
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1456346
Editorial
Accepted on 05 Sep 2024
Molecular Mechanisms and Immunotherapeutic Targets in Nanomedicine-based Cancer Therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1468397
Review
Published on 04 Sep 2024
Exosome in renal cell carcinoma progression and implications for targeted therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1458616
- 295 views
Case Report
Accepted on 02 Sep 2024
Germline CHEK2 Mutation is Associated with a Giant Cell Glioblastoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1361928
Original Research
Accepted on 30 Aug 2024
Resveratrol enhances the anti-liver cancer effect of cisplatin by targeting the cell membrane protein PLA2
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1453164
Review
Published on 30 Aug 2024
Biologic activity and treatment resistance to gastrointestinal cancer: the role of circular RNA in autophagy regulation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1393670
- 298 views
Review
Published on 29 Aug 2024
Long non-coding RNAs in ferroptosis, pyroptosis and necroptosis: From functions to clinical implications in cancer therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1437698
- 235 views
Review
Accepted on 28 Aug 2024
The role and mechanism of compressive stress in tumor
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1459313
Editorial
Accepted on 12 Aug 2024
Editorial: The Role of Post-translational Modifications in Cancer Biology
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1470173
- 208 views
Review
Accepted on 27 Aug 2024
Deciphering the Role of Claudins in Lung Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435535
Original Research
Published on 26 Aug 2024
Acute-phase plasma proteomics of rabbit lung VX2 tumors treated by image-guided microwave ablation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435256
- 495 views